(Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, ...

Terrorism: A Policy Brief on Enhancing PCVE through Collaboration,“ published in RSIS International, conducts a comparative ...

A 1000 mg ×2 induction regimen followed by maintenance every 6–12 months was associated with near-elimination of relapse ...

A new technical paper, “A comparative study on power delivery aspects of compute-in/near-memory approaches using DRAM,” was ...

Just one in four organisations respond effectively to real disruption events as governance and ecosystem lag behind compounding risks ...

Patient-reported opioid consumption after fracture surgery demonstrated good to excellent agreement with traditional blister-pack pill counts.

BV100 is a potential best-in-class anti-infective agent in treating hospital-acquired bacterial pneumonia (HABP) or ventilator-associated bacterial pneumonia (VABP) caused by carbapenem-resistant ...

The European Medicines Agency has finalized its reflection paper on a tailored clinical approach to biosimilar development, revising the wording on when it may waive the need for comparative efficacy ...

The authors say that the paper is correct and that the stents are made by Abbott, and that the registry is inaccurate. An ...

Atropos Health, the pioneer in translating real-world clinical data into personalized real-world evidence (RWE) for clinical decision making, today announced a scientific, multi-layered process for ...

A phase 1b randomized, head-to-head study suggests that the investigational VEGF/Ang2 bispecific antibody OLN324 may offer comparable or improved anatomic and functional outcomes ...

New research reveals that some bottled water may contain far more microscopic plastic particles than tap water, raising ...